国际刊号:
0092-8615
序号 | 标题 | 作者 | 起始页 | 操作 |
---|---|---|---|---|
1 | Editor's Commentary: A Time for Reflection and Anticipation | J. Rick Turner | 687 |
![]() |
2 | Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk-Benefit Assessment | John J. Doyle | 691 |
![]() |
3 | Associate Editor's Commentary: The Danger of Shorting Drug Shortages | Peter J. Pitts | 697 |
![]() |
4 | Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and Wealth | John Vernon | 699 |
![]() |
5 | Preparing for a Safety Inspection | Steve Jolley | 705 |
![]() |
6 | Letter to the Editor | Anonymous | 713 |
![]() |
7 | Ten-year Experience of the Evaluation of Ethnic Sensitivity Data | Chio Ling Hsiao | 717 |
![]() |
8 | Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies | Anonymous | 725 |
![]() |
9 | Platelet Aggregation Quality Control in a Multicenter, Phase 2 Clinical Trial | James McRedmond | 731 |
![]() |
10 | A Longitudinal Model and Graphic for Benefit-risk Analysis, With Case Study | Jonathan D. Norton | 741 |
![]() |